Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2021-10-27 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2021年第三季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (346 characters) indicating that the company's 2021 third quarter report has been published and is available on the official disclosure website. It does not contain the actual financial data or substantive analysis from the report itself, but rather directs investors to where the full report can be found. According to the 'Menu vs Meal' rule, such a brief notice that a report is published and available elsewhere should be classified as a Report Publication Announcement (RPA), not as the Interim/Quarterly Report (IR) itself.
2021-10-27 Chinese
独立董事关于第五届董事会第十三次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors providing prior approval opinions on matters to be discussed at the 13th meeting of the 5th board of directors of Guangzhou Yangpu Medical Technology Co., Ltd. It references compliance with regulatory guidelines and company rules, and it concerns approval of a related party transaction proposal for 2021. The document is short (609 characters) and does not contain financial statements or detailed financial data. It is a governance-related document reflecting board/management information about internal approvals and opinions. Therefore, it fits best under Board/Management Information (MANG).
2021-10-27 Chinese
2021年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "广州阳普医疗科技股份有限公司 2021 年第三季度报告" which translates to "Guangzhou Yangpu Medical Technology Co., Ltd. 2021 Third Quarter Report." It contains detailed financial data including income statement, balance sheet, cash flow statement, and explanations of financial results for the third quarter of 2021. It also includes shareholder information, changes in shareholding, and other operational updates. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2021
2021-10-27 Chinese
关于全资子公司之间吸收合并的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the absorption merger between two wholly-owned subsidiaries of Guangzhou Yangpu Medical Technology Co., Ltd. It details the merger plan, basic information of the merging companies, the merger process, and the impact on the company. The document is a formal announcement of a corporate restructuring event rather than a financial report or regulatory filing. It does not contain financial statements or detailed financial analysis but rather describes the merger transaction and its approval by the board and supervisory committee. This fits the category of a Capital/Financing Update (CAP) as it relates to changes in the company's capital structure and corporate organization through a merger of subsidiaries.
2021-10-12 Chinese
第五届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Guangzhou Yangpu Medical Technology Co., Ltd. It details decisions about the absorption merger of wholly-owned subsidiaries and authorizes management to handle related administrative changes. The document includes voting results and references to related announcements on a regulatory disclosure website. There is no financial data, earnings information, or detailed report content. The focus is on board decisions and management authorizations, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but a meeting resolution announcement.
2021-10-12 Chinese
第五届监事会第十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the supervisory board of Guangzhou Yangpu Medical Technology Co., Ltd. regarding the approval of a merger between two wholly-owned subsidiaries and authorization for management to handle related procedural changes. It includes voting results and references to more detailed announcements on a regulatory disclosure website. The document is short (1510 characters) and primarily serves as an official announcement of decisions made at a board meeting rather than a full report or detailed financial disclosure. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-10-12 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.